Paediatrics Search
Paediatrics Paediatrics
food%20allergy%20(pediatric)
FOOD ALLERGY (PEDIATRIC)
Food allergy is an adverse reaction due to a specific immune response occurring reproducibly upon exposure to certain foods. It occurs minutes to hours after food consumption.
Immunological mechanisms can be IgE mediated, non-IgE mediated or mixed IgE and non-IgE mediated.
It may be life-threatening and is the most common cause of anaphylaxis in children.
It should be differentiated from food intolerance in which adverse reactions from exposure to food arise from non-immunological mechanisms.

Food%20allergy%20(pediatric) Patient Education

Patient Education

Patient/Caregiver Education 

  • Nutritional counseling and regular growth monitoring are recommended for all children with food allergy (FA)
  • Patient and caregivers should be educated on allergy to avoid inadvertent ingestion of food allergens
    • Learn to read food labels, to inquire at restaurants and take precautionary measures to prevent unintentional exposure to known food allergens
  • Medical information bracelet or necklace for the patient can provide important medical details when patient is found unconscious or cannot communicate due to the food-induced adverse reaction
  • FA action plan should be developed, containing steps to take in case of a reaction
    • Include doses of medications and contact information for family members and healthcare providers
    • This plan should be thoroughly discussed with patients, family members and caregivers
    • Patients with history of food-induced anaphylaxis need to know how to use self-injectable Epinephrine
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Product Highlight - ADACEL
5 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Carfilzomib-based triplet regimen a potential upfront treatment for high-risk MM
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Alzheimer’s disease prevention: Can antidepressants lend a hand?
Jairia Dela Cruz, 4 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Empagliflozin not just another SGLT2i: Cardio-renal benefits extend to HF with or without diabetes
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.